Project entitled """"""""Physiological, Anatomical and Cell Biological Regulation of Phosphoproteins in the Basal Ganglia,"""""""" focuses on elucidating the molecular mechanisms whereby dopamine regulates neurotransmitter receptors and voltage-gated ion channels in the neostriatum. In particular, we will study protein phosphatase-12 (PP1) and its regulatory proteins, DARPP-32 (dopamine- and cAMP-regulated phosphoprotein, Mr 32 kD), spinophilin and neurabin using the tools of electrophysiology and microscopy, in conjunction with gene-targeting (Project IV).
Specific Aim I will be to characterize the roles of these proteins in the dopaminergic regulation of AMPA, NMDA, GABAA and voltage-gated Ca2+ channels in mice bearing gene-disruptions of PP1, DARPP-32, spinophilin or neurabin. We will also examine potential aberrations in the dopamine-mediate regulation of synaptic transmission and plasticity in the gene-disrupted mice.
Specific Aim II will be to study the subcellular and regional distribution of neurabin in the brain to provide insight into all the physiological role of this newly discovered protein. Moreover, we will investigate the roles of neurabin, spinophilin and PP1 in the regulation of neuronal morphology.
Specific Aim III will be to determine how spinophilin is targeted in the vicinity of ion channels and how the localization of the spinophilin-PP1 and neurabin-PP1 complexes is dynamically regulated in neurons. Elucidation of these three aims is essential for understanding the molecular and cellular basis of dopamine action and may result in new opportunities for the treatment of dopamine-related neurodegenerative and neuropsychiatric diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Program Projects (P01)
Project #
2P01MH040899-16
Application #
6347615
Study Section
Project Start
2000-08-26
Project End
2001-06-30
Budget Start
Budget End
Support Year
16
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Rockefeller University
Department
Type
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Plattner, Florian; Hayashi, Kanehiro; Hernández, Adan et al. (2015) The role of ventral striatal cAMP signaling in stress-induced behaviors. Nat Neurosci 18:1094-100
Kimura, Toru; Han, Wonsun; Pagel, Philipp et al. (2011) Protein phosphatase 2A interacts with the Na,K-ATPase and modulates its trafficking by inhibition of its association with arrestin. PLoS One 6:e29269
Zhou, Mingming; Rebholz, Heike; Brocia, Christine et al. (2010) Forebrain overexpression of CK1delta leads to down-regulation of dopamine receptors and altered locomotor activity reminiscent of ADHD. Proc Natl Acad Sci U S A 107:4401-6
Bertran-Gonzalez, Jesus; HÃ¥kansson, Kerstin; Borgkvist, Anders et al. (2009) Histone H3 phosphorylation is under the opposite tonic control of dopamine D2 and adenosine A2A receptors in striatopallidal neurons. Neuropsychopharmacology 34:1710-20
Kuroiwa, Mahomi; Bateup, Helen S; Shuto, Takahide et al. (2008) Regulation of DARPP-32 phosphorylation by three distinct dopamine D1-like receptor signaling pathways in the neostriatum. J Neurochem 107:1014-26
Nishi, Akinori; Kuroiwa, Mahomi; Miller, Diane B et al. (2008) Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum. J Neurosci 28:10460-71
Barbano, Paolo E; Spivak, Marina; Flajolet, Marc et al. (2007) A mathematical tool for exploring the dynamics of biological networks. Proc Natl Acad Sci U S A 104:19169-74
Borgkvist, Anders; Usiello, Alessandro; Greengard, Paul et al. (2007) Activation of the cAMP/PKA/DARPP-32 signaling pathway is required for morphine psychomotor stimulation but not for morphine reward. Neuropsychopharmacology 32:1995-2003
Bullock, S Andrew; Platholi, Jimcy; Gjyrezi, Ada et al. (2007) Differential regulation of protein phosphatase-1(I) by neurabin. Biochem Biophys Res Commun 358:140-4
Svenningsson, Per; Bateup, Helen; Qi, Hongshi et al. (2007) Involvement of AMPA receptor phosphorylation in antidepressant actions with special reference to tianeptine. Eur J Neurosci 26:3509-17

Showing the most recent 10 out of 219 publications